Santhanam Anantha Vijay R, d'Uscio Livius V, Katusic Zvonimir S
Departments of Anesthesiology and Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Departments of Anesthesiology and Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Brain Res. 2015 Nov 2;1625:198-205. doi: 10.1016/j.brainres.2015.08.034. Epub 2015 Sep 3.
Tetrahydrobiopterin (BH4) is a critical determinant of nitric oxide (NO) production by nitric oxide synthase (NOS) in the vascular endothelium and its biosynthesis is regulated by the enzymatic activity of GTP-cyclohydrolase I (GTPCH I). The present study was designed to determine the effects of endothelium-targeted overexpression of GTPCH I (eGCH-Tg) on murine cerebral vascular function. Endothelium targeted over-expression of GTPCH I was associated with a significant increase in levels of BH4, as well as its oxidized product, 7,8-dihydrobiopterin (7,8-BH2) in cerebral microvessels. Importantly, ratio of BH4 to 7,8-BH2, indicative of BH4 available for eNOS activation, was significantly increased in eGCH-Tg mice. However, expression of endothelial NOS, levels of nitrate/nitrite--indicative of NO production--remained unchanged between cerebral microvessels of wild-type and eGCH-Tg mice. Furthermore, increased BH4 biosynthesis neither affected production of superoxide anion nor expression of antioxidant proteins. Moreover, endothelium-specific GTPCH I overexpression did not alter intracellular levels of cGMP, reflective of NO signaling in cerebral microvessels. The obtained results suggest that, despite a significant increase in BH4 bioavailability, generation of endothelial NO in cerebral microvessels remained unchanged in eGCH-Tg mice. We conclude that under physiological conditions the levels of BH4 in the cerebral microvessels are optimal for activation of endothelial NOS and NO/cGMP signaling.
四氢生物蝶呤(BH4)是血管内皮中一氧化氮合酶(NOS)产生一氧化氮(NO)的关键决定因素,其生物合成受鸟苷三磷酸环化水解酶I(GTPCH I)的酶活性调节。本研究旨在确定内皮靶向性过表达GTPCH I(eGCH-Tg)对小鼠脑血管功能的影响。内皮靶向性过表达GTPCH I与脑微血管中BH4及其氧化产物7,8-二氢生物蝶呤(7,8-BH2)水平的显著升高有关。重要的是,在eGCH-Tg小鼠中,指示可用于激活内皮型一氧化氮合酶(eNOS)的BH4与7,8-BH2的比率显著增加。然而,野生型和eGCH-Tg小鼠脑微血管之间内皮型一氧化氮合酶的表达、指示NO产生的硝酸盐/亚硝酸盐水平保持不变。此外,增加的BH4生物合成既不影响超氧阴离子的产生,也不影响抗氧化蛋白的表达。此外,内皮特异性GTPCH I过表达并未改变反映脑微血管中NO信号的细胞内cGMP水平。所得结果表明,尽管BH4的生物利用度显著增加,但eGCH-Tg小鼠脑微血管中内皮NO的生成仍保持不变。我们得出结论,在生理条件下,脑微血管中BH4的水平对于激活内皮型一氧化氮合酶以及NO/cGMP信号传导是最佳的。